J&J | Pasivo Circulante



Current Liabilities Cambio Fecha
AbbVie USD 38.75B 4.31B 2024-12
Abbott USD 13B 1.15B 2025-03
Amgen USD 23.01B 91M 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Baxter International USD 6.51B 311M 2024-12
Bayer EUR 27.96B 993M 2025-03
Becton, Dickinson and Co. USD 7.69B 27M 2025-03
Biogen USD 5.3B 231.4M 2025-03
Boston Scientific USD 5.06B 1.34B 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
CONMED USD 283.15M 5.02M 2025-03
Cooper Companies USD 999.6M 23.2M 2025-01
Dexcom USD 3.04B 105.1M 2025-03
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Eli Lilly USD 30.07B 1.69B 2025-03
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Globus Medical USD 384.7M 471.21M 2025-03
Hologic USD 989.7M 12.7M 2025-03
Indivior 1.01B 66M 2025-03
Insulet USD 520.4M 8M 2025-03
Integra LifeSciences USD 918.45M 3.67M 2025-03
Intuitive Surgical USD 2.01B 200.9M 2025-03
J&J USD 56.9B 6.58B 2025-03
Medtronic USD 12.88B 1.04B 2025-04
Merck USD 25.17B 3.25B 2025-03
Merit Medical Systems USD 196.82M 19.58M 2025-03
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03
Stryker USD 7.93B 313M 2025-03
Tandem Diabetes Care USD 288.18M 41.13M 2025-03
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12
Zoetis USD 3.38B 27M 2025-03



J&J Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.